Showing results (2021-2030 of 2,463) with videos related to

Sort By:
Pageof 247
Journal of Law and the Biosciences|June 10, 2024
Ethical, legal, and policy challenges in field-based neuroimaging research using emerging portable MRI technologies: guidance for investigators and for oversightFrancis X Shen, Susan M Wolf, Frances Lawrenz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast CancerKim R M Blenman, Michal Marczyk, Thomas Karn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2019
Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breathR de Vries, M Muller, V van der Noort, et al.
Annals of Internal Medicine|October 1, 1994
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trialD W Maher, G J Lieschke, M Green, et al.
Journal of Medicinal Chemistry|February 18, 2010
1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: a novel series of potent calcium-sensing receptor antagonistsLeo Widler, Eva Altmann, René Beerli, et al.
European Journal of Human Genetics : EJHG|January 29, 2009
Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4)Lisa J Strug, Tara Clarke, Theodore Chiang, et al.
Journal of Natural Products|February 8, 2020
Antimycobacterial Rufomycin Analogues from Streptomyces atratus Strain MJM3502Bin Zhou, Gauri Shetye, Yang Yu, et al.
NPJ Breast Cancer|September 27, 2017
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trialDenise M Wolf, Christina Yau, Ashish Sanil, et al.
Breast Cancer Research : BCR|August 31, 2017
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant settingTesa M Severson, Denise M Wolf, Christina Yau, et al.
JCI Insight|July 3, 2025
Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosisAbhishek Basu, Muhammad Arif, Kaelin M Wolf, et al.
Pageof 247